Oncocyte Corp Annual Return On Equity in % from 2016 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Oncocyte Corp quarterly/annual Return On Equity history and growth rate from 2016 to 2023.
  • Oncocyte Corp Return On Equity for the quarter ending June 30, 2024 was -157 %, a 25.6% decline year-over-year.
  • Oncocyte Corp annual Return On Equity for 2023 was -80.4 %, a 30.7% increase from 2022.
  • Oncocyte Corp annual Return On Equity for 2022 was -116 %, a 69.2% decline from 2021.
  • Oncocyte Corp annual Return On Equity for 2021 was -68.6 %, a 17.3% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -80.4 +35.6 +30.7% Jan 1, 2023 Dec 31, 2023
2022 -116 -47.4 -69.2% Jan 1, 2022 Dec 31, 2022
2021 -68.6 +14.4 +17.3% Jan 1, 2021 Dec 31, 2021
2020 -83 -14.9 -21.9% Jan 1, 2020 Dec 31, 2020
2019 -68 +167 +71.1% Jan 1, 2019 Dec 31, 2019
2018 -235 +53.5 +18.5% Jan 1, 2018 Dec 31, 2018
2017 -289 -157 -119% Jan 1, 2017 Dec 31, 2017
2016 -132 Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.